\-\ Texto\\:\\ \ \(0\)\
\-\ physical\\ exam\\ revealed\\ decreased\\ breath\\ sound\\,\\ poor\\ ventilation\\,\\ and\\ expiratory\\ wheezing\\.\\ \\ laboratory\\ assessment\\ \\(cbc\\,\\ chem\\)\\ were\\ unrevealing\\.\\ \\ prior\\ labs\\ revealed\\ no\\ hormonal\\ abnormalities\\.\ \(0\)\
\-\ progression\\ of\\ imaging\\ findings\\ is\\ compatible\\ with\\ worsening\\ metastatic\\ disease\\ from\\ paraganglioma\\.\\ \\ the\\ original\\ site\\ of\\ tumor\\ \\(head\\+neck\\,\\ adrenal\\,\\ extra\\-adrenal\\)\\ has\\ not\\ been\\ confirmed\\,\\ but\\ no\\ adrenal\\ lesion\\ was\\ discovered\\.\\ \\ a\\ laryngeal\\ lesion\\ was\\ found\\ recently\\,\\ but\\ this\\ may\\ also\\ be\\ metastatic\\.\\ \\ the\\ chest\\ lesions\\ have\\ not\\ been\\ biopsied\\ due\\ to\\ concern\\ for\\ bleeding\\ \\-\\-\\ but\\ they\\ are\\ presumed\\ to\\ be\\ metastatic\\ in\\ nature\\.\\ \\ \\ the\\ patient\\ has\\ had\\ radiotherapy\\ to\\ the\\ spine\\ \\(which\\ has\\ partially\\ improved\\ multilevel\\ degenerative\\ disc\\ abnormalities\\)\\.\\ \\ chest\\ radiation\\ is\\ being\\ considered\\.\ \(0\)\
\-\ cxr\\ reveals\\ multiple\\ pulmonary\\ nodules\\.\\ \\ there\\ is\\ also\\ a\\ large\\ middle\\ mediastinal\\ mass\\ encasing\\ the\\ trachea\\.\\ \\ chest\\ ct\\ reveals\\ that\\ the\\ mass\\ is\\ hypervascular\\ in\\ its\\ periphery\\,\\ with\\ the\\ center\\ of\\ the\\ mass\\ being\\ hypovascular\\ and\\ potentially\\ partially\\ calcified\\.\ \(0\)\
\-\ metastatic\\ paraganglioma\ \(1\)\
\-\ \\â\\€\\¢\\ vascular\\ mass\\ \\-\\ hemangioma\\,\\ angiosarcoma\\,\\ partially\\ thrombosed\\ aneurysm\ \(0\)\
\-\ \\â\\€\\¢\\ neoplasms\\ \\-\\ metastatic\\ hypervascular\\ tumors\\ \\(thyroid\\,\\ hcc\\,\\ melanoma\\,\\ breast\\,\\ rcc\\,\\ neuroendocrine\\ tumors\\,\\ sarcomas\\)\ \(0\)\
\-\ \\â\\€\\¢\\ svc\\ syndrome\\ with\\ vascular\\ collaterals\\ simulating\\ a\\ hypervascular\\ lesion\\,\\ making\\ lung\\ cancer\\,\\ lymphoma\\,\\ and\\ other\\ hypervascular\\ lesions\\ a\\ possibility\\.\ \(0\)\
\-\ 73\\ yo\\ man\\ with\\ copd\\ and\\ chronic\\ back\\ pain\\ from\\ degenerative\\ disc\\ disease\\ and\\ spinal\\ stenosis\\.\\ he\\ presents\\ today\\ with\\ shortness\\ of\\ breath\\ to\\ the\\ er\\.\\ \\ cxr\\ and\\ chest\\ ct\\ were\\ performed\\ during\\ the\\ workup\\ and\\ are\\ shown\\ in\\ figures\\ 1\\ and\\ 2\\.\\ \\ comparison\\ chest\\ cts\\ \\(not\\ shown\\)\\ revealed\\ only\\ mild\\ progression\\ of\\ the\\ findings\\ over\\ the\\ past\\ 5\\ years\\.\ \(0\)\
\-\ pmh\\ is\\ significant\\:\\ more\\ than\\ a\\ decade\\ earlier\\,\\ a\\ routine\\ cxr\\ showed\\ multiple\\ pulmonary\\ nodules\\ and\\ a\\ mediastinal\\ mass\\ was\\ evaluated\\ by\\ ct\\.\\ \\ gallium\\ scan\\ at\\ that\\ time\\ was\\ positive\\.\\ \\ nine\\ years\\ prior\\,\\ he\\ presented\\ with\\ worsening\\ back\\ pain\\ and\\ was\\ found\\ to\\ have\\ an\\ osteolytic\\ lesion\\ at\\ the\\ l3\\ vertebral\\ body\\.\\ \\ biopsy\\ was\\ performed\\ identifying\\ the\\ diagnosis\\.\ \(0\)\
\-\ paraganglioma\\ is\\ uncommon\\,\\ and\\ metastatic\\ paraganglioma\\ is\\ rare\\.\\ \\ most\\ primary\\ lesions\\ are\\ in\\ the\\ head\\+neck\\,\\ adrenal\\ gland\\,\\ or\\ paraspinal\\.\\ \\ these\\ hypervascular\\ tumors\\ are\\ usually\\ slow\\ growing\\ and\\ usually\\ non\\-malignant\\,\\ but\\ treatment\\ is\\ needed\\ as\\ the\\ 5\\-year\\ survival\\ can\\ drop\\ to\\ 20\\%\\.\\ \\ in\\ the\\ past\\,\\ surgical\\ resection\\ \\(perhaps\\ with\\ prior\\ embolization\\ by\\ ir\\)\\ was\\ the\\ definitive\\ treatment\\,\\ but\\ recent\\ treatment\\ has\\ focused\\ on\\ radiotherapy\\.\\ \\ 5\\-year\\ survival\\ rates\\ with\\ treatment\\ can\\ be\\ above\\ 75\\%\\.\\ \\ in\\ the\\ setting\\ of\\ widespread\\ metastatic\\ disease\\,\\ 5\\-year\\ survival\\ rates\\ may\\ drop\\ to\\ 36\\%\\.\ \(0\)\
\-\ references\\:\ \(0\)\
\-\ lee\\ ky\\ et\\.\\ al\\.\\ \\ extraadrenal\\ paragangliomas\\ of\\ the\\ body\\:\\ imaging\\ features\\.\\ \\ ajr\\ 2006\\;\\ 187\\:\\ 492\\-504\\.\ \(0\)\
\-\ trombetta\\ m\\ et\\.\\ al\\.\\ \\ paraganglioma\\:\\ a\\ potentially\\ challenging\\ tumor\\.\\ \\ oncology\\ 2008\\;\\ 22\\(3\\)\\ \\-\\ online\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ paraganglioma\\:\\ 0\\.2651885910426812\ \(0\)\
\-\ hypervascular\\:\\ 0\\.2577830240678277\ \(0\)\
\-\ the\\:\\ 0\\.1945895920040857\ \(0\)\
\-\ metastatic\\:\\ 0\\.18719873120286937\ \(0\)\
\-\ adrenal\\:\\ 0\\.18063701876142624\ \(0\)\
\-\ survival\\:\\ 0\\.14276326817036705\ \(0\)\
\-\ chest\\:\\ 0\\.12869122176801376\ \(0\)\
\-\ partially\\:\\ 0\\.12554384367115162\ \(0\)\
\-\ and\\:\\ 0\\.12090903760706691\ \(0\)\
\-\ but\\:\\ 0\\.12056063085336924\ \(0\)\
\-\ was\\:\\ 0\\.11895453378975747\ \(0\)\
\-\ cxr\\:\\ 0\\.11702261113882538\ \(0\)\
\-\ tumors\\:\\ 0\\.10758243576027532\ \(0\)\
\-\ is\\:\\ 0\\.10682707710046332\ \(0\)\
\-\ drop\\:\\ 0\\.10607543641707248\ \(0\)\
\-\ radiotherapy\\:\\ 0\\.10561952015233694\ \(0\)\
\-\ potentially\\:\\ 0\\.10235326910723985\ \(0\)\
\-\ rates\\:\\ 0\\.10162567646215065\ \(0\)\
\-\ revealed\\:\\ 0\\.0959159265320916\ \(0\)\
\-\ lesion\\:\\ 0\\.09350740664218457\ \(0\)\
\-\ mass\\:\\ 0\\.09312597991953817\ \(0\)\
\-\ treatment\\:\\ 0\\.09290878729788253\ \(0\)\
\-\ progression\\:\\ 0\\.08942323432663019\ \(0\)\
\-\ has\\:\\ 0\\.08908943872739196\ \(0\)\
\-\ to\\:\\ 0\\.08533014340585925\ \(0\)\
\-\ disc\\:\\ 0\\.08472452760186687\ \(0\)\
\-\ lesions\\:\\ 0\\.08401106463695386\ \(0\)\
\-\ degenerative\\:\\ 0\\.08284396915686774\ \(0\)\
\-\ prior\\:\\ 0\\.0818446976030295\ \(0\)\
\-\ mediastinal\\:\\ 0\\.07874655879155093\ \(0\)\
\-\ ky\\:\\ 0\\.07797859882637687\ \(0\)\
\-\ extraadrenal\\:\\ 0\\.07797859882637687\ \(0\)\
\-\ trombetta\\:\\ 0\\.07797859882637687\ \(0\)\
\-\ nodules\\:\\ 0\\.07748629441254709\ \(0\)\
\-\ al\\:\\ 0\\.07748629441254709\ \(0\)\
\-\ et\\:\\ 0\\.07639380480829513\ \(0\)\
\-\ with\\:\\ 0\\.07638326924844091\ \(0\)\
\-\ shown\\:\\ 0\\.07559850575101715\ \(0\)\
\-\ worsening\\:\\ 0\\.0744708984428751\ \(0\)\
\-\ reveals\\:\\ 0\\.0741823540957207\ \(0\)\
\-\ are\\:\\ 0\\.07400951552072825\ \(0\)\
\-\ in\\:\\ 0\\.0727801273857775\ \(0\)\
\-\ breath\\:\\ 0\\.07147563619003125\ \(0\)\
\-\ abnormalities\\:\\ 0\\.07064152702134727\ \(0\)\
\-\ gallium\\:\\ 0\\.07014621586920661\ \(0\)\
\-\ being\\:\\ 0\\.0679564210218296\ \(0\)\
\-\ paragangliomas\\:\\ 0\\.06727007697573269\ \(0\)\
\-\ of\\:\\ 0\\.06679545032673205\ \(0\)\
\-\ unrevealing\\:\\ 0\\.06612866086460348\ \(0\)\
\-\ hypovascular\\:\\ 0\\.06612866086460348\ \(0\)\
\-\ 187\\:\\ 0\\.06612866086460348\ \(0\)\
\-\ back\\:\\ 0\\.06503943333405353\ \(0\)\
\-\ vascular\\:\\ 0\\.06438181969266021\ \(0\)\
\-\ body\\:\\ 0\\.06418139715414078\ \(0\)\
\-\ past\\:\\ 0\\.06347872920618021\ \(0\)\
\-\ neuroendocrine\\:\\ 0\\.06340654277533893\ \(0\)\
\-\ simulating\\:\\ 0\\.06340654277533893\ \(0\)\
\-\ online\\:\\ 0\\.06340654277533893\ \(0\)\
\-\ found\\:\\ 0\\.06310048707998327\ \(0\)\
\-\ encasing\\:\\ 0\\.06266277619284873\ \(0\)\
\-\ challenging\\:\\ 0\\.06266277619284873\ \(0\)\
\-\ disease\\:\\ 0\\.06140373301879232\ \(0\)\
\-\ usually\\:\\ 0\\.06139303873143722\ \(0\)\
\-\ sarcomas\\:\\ 0\\.061345107994845986\ \(0\)\
\-\ lee\\:\\ 0\\.061345107994845986\ \(0\)\
\-\ cts\\:\\ 0\\.06075536221656515\ \(0\)\
\-\ hormonal\\:\\ 0\\.06020369188371679\ \(0\)\
\-\ years\\:\\ 0\\.05977902523567565\ \(0\)\
\-\ expiratory\\:\\ 0\\.05968547726232831\ \(0\)\
\-\ laryngeal\\:\\ 0\\.05968547726232831\ \(0\)\
\-\ multilevel\\:\\ 0\\.05968547726232831\ \(0\)\
\-\ ir\\:\\ 0\\.05968547726232831\ \(0\)\
\-\ pulmonary\\:\\ 0\\.05944350275534965\ \(0\)\
\-\ be\\:\\ 0\\.05934051402130401\ \(0\)\
\-\ collaterals\\:\\ 0\\.059196891521093954\ \(0\)\
\-\ figures\\:\\ 0\\.059196891521093954\ \(0\)\
\-\ angiosarcoma\\:\\ 0\\.05787922332309122\ \(0\)\
\-\ thrombosed\\:\\ 0\\.05787922332309122\ \(0\)\
\-\ focused\\:\\ 0\\.05787922332309122\ \(0\)\
\-\ not\\:\\ 0\\.057748415155935116\ \(0\)\
\-\ he\\:\\ 0\\.057748320110071444\ \(0\)\
\-\ performed\\:\\ 0\\.057693700744978156\ \(0\)\
\-\ biopsied\\:\\ 0\\.057481573794452234\ \(0\)\
\-\ rcc\\:\\ 0\\.057481573794452234\ \(0\)\
\-\ nine\\:\\ 0\\.05710160353450663\ \(0\)\
\-\ osteolytic\\:\\ 0\\.05710160353450663\ \(0\)\
\-\ widespread\\:\\ 0\\.05710160353450663\ \(0\)\
\-\ been\\:\\ 0\\.056816798445734236\ \(0\)\
\-\ sound\\:\\ 0\\.056737807211962026\ \(0\)\
\-\ hcc\\:\\ 0\\.05638886393114965\ \(0\)\
\-\ today\\:\\ 0\\.056053608280749796\ \(0\)\
\-\ perhaps\\:\\ 0\\.056053608280749796\ \(0\)\
\-\ chem\\:\\ 0\\.0557310068493392\ \(0\)\
\-\ ct\\:\\ 0\\.05569070056035785\ \(0\)\
\-\ svc\\:\\ 0\\.05455010834299802\ \(0\)\
\-\ ajr\\:\\ 0\\.05455010834299802\ \(0\)\
\-\ identifying\\:\\ 0\\.054015689122697476\ \(0\)\
\-\ ventilation\\:\\ 0\\.05216023836641409\ \(0\)\
\-\ oncology\\:\\ 0\\.05216023836641409\ \(0\)\
\-\ copd\\:\\ 0\\.05195425434220453\ \(0\)\
\-\ original\\:\\ 0\\.05175311745357489\ \(0\)\
\-\ decade\\:\\ 0\\.05136450856392369\ \(0\)\
\-\ imaging\\:\\ 0\\.05125054911820987\ \(0\)\
\-\ can\\:\\ 0\\.05117589464703448\ \(0\)\
\-\ tumor\\:\\ 0\\.0510091045754751\ \(0\)\
\-\ wheezing\\:\\ 0\\.05046389495026295\ \(0\)\
\-\ were\\:\\ 0\\.0502692216015084\ \(0\)\
\-\ 73\\:\\ 0\\.050128639299863095\ \(0\)\
\-\ presumed\\:\\ 0\\.0498060378684525\ \(0\)\
\-\ 2008\\:\\ 0\\.0498060378684525\ \(0\)\
\-\ periphery\\:\\ 0\\.049195212120508924\ \(0\)\
\-\ may\\:\\ 0\\.049075607081126384\ \(0\)\
\-\ compatible\\:\\ 0\\.048764133048416924\ \(0\)\
\-\ making\\:\\ 0\\.048764133048416924\ \(0\)\
\-\ have\\:\\ 0\\.048717053778319676\ \(0\)\
\-\ 2006\\:\\ 0\\.048625139362111325\ \(0\)\
\-\ l3\\:\\ 0\\.048353753921943396\ \(0\)\
\-\ findings\\:\\ 0\\.048130490606877366\ \(0\)\
\-\ growing\\:\\ 0\\.04783553930055492\ \(0\)\
\-\ assessment\\:\\ 0\\.04771074988186517\ \(0\)\
\-\ multiple\\:\\ 0\\.04769960937561954\ \(0\)\
\-\ paraspinal\\:\\ 0\\.04746650688390103\ \(0\)\
\-\ trachea\\:\\ 0\\.04722904929876879\ \(0\)\
\-\ slow\\:\\ 0\\.04699801027850819\ \(0\)\
\-\ comparison\\:\\ 0\\.046446339945659824\ \(0\)\
\-\ workup\\:\\ 0\\.045928125324271346\ \(0\)\
\-\ also\\:\\ 0\\.04587105065289664\ \(0\)\
\-\ melanoma\\:\\ 0\\.04553504810029668\ \(0\)\
\-\ neoplasms\\:\\ 0\\.045439539583037\ \(0\)\
\-\ possibility\\:\\ 0\\.0453450864301056\ \(0\)\
\-\ setting\\:\\ 0\\.0453450864301056\ \(0\)\
\-\ concern\\:\\ 0\\.04471161716331509\ \(0\)\
\-\ earlier\\:\\ 0\\.04453892596937625\ \(0\)\
\-\ definitive\\:\\ 0\\.04453892596937625\ \(0\)\
\-\ discovered\\:\\ 0\\.04445387130377557\ \(0\)\
\-\ center\\:\\ 0\\.044121871385034254\ \(0\)\
\-\ pmh\\:\\ 0\\.044121871385034254\ \(0\)\
\-\ uncommon\\:\\ 0\\.044121871385034254\ \(0\)\
\-\ improved\\:\\ 0\\.04327024313962223\ \(0\)\
\-\ nature\\:\\ 0\\.04305198643079742\ \(0\)\
\-\ 75\\:\\ 0\\.04276938471377263\ \(0\)\
\-\ recently\\:\\ 0\\.04256340068956307\ \(0\)\
\-\ embolization\\:\\ 0\\.04249582782094063\ \(0\)\
\-\ that\\:\\ 0\\.04232042649150446\ \(0\)\
\-\ evaluated\\:\\ 0\\.041662787075902326\ \(0\)\
\-\ by\\:\\ 0\\.04141304289493121\ \(0\)\
\-\ poor\\:\\ 0\\.041130218255731564\ \(0\)\
\-\ hemangioma\\:\\ 0\\.04101624425565923\ \(0\)\
\-\ cbc\\:\\ 0\\.0406831661427482\ \(0\)\
\-\ 36\\:\\ 0\\.040362581444475694\ \(0\)\
\-\ needed\\:\\ 0\\.040258337184640516\ \(0\)\
\-\ bleeding\\:\\ 0\\.03985362617409134\ \(0\)\
\-\ gland\\:\\ 0\\.03961007911940999\ \(0\)\
\-\ site\\:\\ 0\\.03932669659184654\ \(0\)\
\-\ calcified\\:\\ 0\\.03928036627047928\ \(0\)\
\-\ features\\:\\ 0\\.039234285709469865\ \(0\)\
\-\ shortness\\:\\ 0\\.03909751601780831\ \(0\)\
\-\ references\\:\\ 0\\.038874319959862395\ \(0\)\
\-\ from\\:\\ 0\\.038731178991281395\ \(0\)\
\-\ 22\\:\\ 0\\.038402886428357125\ \(0\)\
\-\ thyroid\\:\\ 0\\.038319896229223716\ \(0\)\
\-\ considered\\:\\ 0\\.03799576551551792\ \(0\)\
\-\ routine\\:\\ 0\\.03776048671670123\ \(0\)\
\-\ vertebral\\:\\ 0\\.03723544922143755\ \(0\)\
\-\ aneurysm\\:\\ 0\\.03712701744991072\ \(0\)\
\-\ stenosis\\:\\ 0\\.03709117704786035\ \(0\)\
\-\ at\\:\\ 0\\.036834889894219264\ \(0\)\
\-\ rare\\:\\ 0\\.036809738511428096\ \(0\)\
\-\ er\\:\\ 0\\.036470490680664804\ \(0\)\
\-\ its\\:\\ 0\\.03608040367872113\ \(0\)\
\-\ confirmed\\:\\ 0\\.035954232777464144\ \(0\)\
\-\ laboratory\\:\\ 0\\.03540843528810763\ \(0\)\
\-\ breast\\:\\ 0\\.03540843528810763\ \(0\)\
\-\ above\\:\\ 0\\.035176612988879544\ \(0\)\
\-\ pain\\:\\ 0\\.03489657770029677\ \(0\)\
\-\ middle\\:\\ 0\\.03486778742405436\ \(0\)\
\-\ they\\:\\ 0\\.03484025785640652\ \(0\)\
\-\ spinal\\:\\ 0\\.03462315606947099\ \(0\)\
\-\ biopsy\\:\\ 0\\.03417934739954444\ \(0\)\
\-\ labs\\:\\ 0\\.03378169787090545\ \(0\)\
\-\ recent\\:\\ 0\\.033015700005751075\ \(0\)\
\-\ cancer\\:\\ 0\\.03247791744747043\ \(0\)\
\-\ showed\\:\\ 0\\.03247791744747043\ \(0\)\
\-\ radiation\\:\\ 0\\.03231273504424384\ \(0\)\
\-\ spine\\:\\ 0\\.0322110938542116\ \(0\)\
\-\ positive\\:\\ 0\\.03213064221688603\ \(0\)\
\-\ no\\:\\ 0\\.03171269681556599\ \(0\)\
\-\ 20\\:\\ 0\\.03145722931027989\ \(0\)\
\-\ resection\\:\\ 0\\.03125609242165024\ \(0\)\
\-\ during\\:\\ 0\\.0308847695305414\ \(0\)\
\-\ yo\\:\\ 0\\.03046277252144989\ \(0\)\
\-\ only\\:\\ 0\\.03046277252144989\ \(0\)\
\-\ decreased\\:\\ 0\\.030203233089108102\ \(0\)\
\-\ primary\\:\\ 0\\.029982425743134006\ \(0\)\
\-\ lung\\:\\ 0\\.02966155448547006\ \(0\)\
\-\ syndrome\\:\\ 0\\.029395794529786936\ \(0\)\
\-\ lymphoma\\:\\ 0\\.029039876198921157\ \(0\)\
\-\ chronic\\:\\ 0\\.028942818443167664\ \(0\)\
\-\ scan\\:\\ 0\\.02892904257658225\ \(0\)\
\-\ time\\:\\ 0\\.028901557268765796\ \(0\)\
\-\ presented\\:\\ 0\\.02843434134707693\ \(0\)\
\-\ significant\\:\\ 0\\.028153218381611257\ \(0\)\
\-\ due\\:\\ 0\\.02802842896292151\ \(0\)\
\-\ mild\\:\\ 0\\.027640921325960084\ \(0\)\
\-\ than\\:\\ 0\\.027640921325960084\ \(0\)\
\-\ these\\:\\ 0\\.027535026908639623\ \(0\)\
\-\ over\\:\\ 0\\.02711296230752855\ \(0\)\
\-\ more\\:\\ 0\\.026774710614559254\ \(0\)\
\-\ physical\\:\\ 0\\.02643904350186824\ \(0\)\
\-\ man\\:\\ 0\\.025814395622203407\ \(0\)\
\-\ most\\:\\ 0\\.025376422557727474\ \(0\)\
\-\ other\\:\\ 0\\.02532209235342993\ \(0\)\
\-\ diagnosis\\:\\ 0\\.025277079488137327\ \(0\)\
\-\ exam\\:\\ 0\\.02454604250348166\ \(0\)\
\-\ large\\:\\ 0\\.024431413460843925\ \(0\)\
\-\ had\\:\\ 0\\.02429425648588184\ \(0\)\
\-\ surgical\\:\\ 0\\.023699176589882732\ \(0\)\
\-\ presents\\:\\ 0\\.023456300611902927\ \(0\)\
\-\ which\\:\\ 0\\.022171868609808916\ \(0\)\
\-\ as\\:\\ 0\\.019588809344838955\ \(0\)\
\-\ there\\:\\ 0\\.01940163772351488\ \(0\)\
\-\ an\\:\\ 0\\.01864583816579649\ \(0\)\
\-\ or\\:\\ 0\\.016962897549411302\ \(0\)\
\-\ this\\:\\ 0\\.016754973901103073\ \(0\)\
\-\ patient\\:\\ 0\\.01585933145557671\ \(0\)\
\-\ for\\:\\ 0\\.014778922740864845\ \(0\)\
\-\ on\\:\\ 0\\.014726497410228166\ \(0\)\
